GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (FRA:7CA) » Definitions » Beginning Cash Position

Camurus AB (FRA:7CA) Beginning Cash Position : €105.1 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Camurus AB Beginning Cash Position?

Camurus AB's Beginning Cash Position for the quarter that ended in Mar. 2024 was €105.1 Mil.

Camurus AB's quarterly Beginning Cash Position increased from Sep. 2023 (€55.3 Mil) to Dec. 2023 (€103.2 Mil) and increased from Dec. 2023 (€103.2 Mil) to Mar. 2024 (€105.1 Mil).

Camurus AB's annual Beginning Cash Position declined from Dec. 2021 (€45.0 Mil) to Dec. 2022 (€37.4 Mil) but then increased from Dec. 2022 (€37.4 Mil) to Dec. 2023 (€50.6 Mil).


Camurus AB Beginning Cash Position Historical Data

The historical data trend for Camurus AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Beginning Cash Position Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.82 35.26 44.96 37.44 50.56

Camurus AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.42 50.21 55.29 103.15 105.14

Camurus AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Camurus AB Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Camurus AB's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB (FRA:7CA) Business Description

Industry
Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (FRA:7CA) Headlines

No Headlines